Advanced platelet-concentrating technology for optimising ARM patient outcomes
Alocuro provides a comprehensive portfolio of medical devices, equipment & advanced training.
Supporting doctors to obtain patient-customised, autologous PRP & PRF products for point-of-care procedures.
Our Approach
Alocuro is 100% Australian-owned and operated medical consultancy specialising in clinically-justified, regenerative medicine technologies. Founded in 2014 by a group of healthcare practitioners, we provide more than just medical devices; our service spans clinical education, workflow design, OH&S compliance, patient protocols, and all required documentation for seamless integration of evidence-based, autologous (patient’s own) blood component therapies into your practice.
Our platelet-concentrating systems utilise minimally manipulated, patient-derived, blood products to promote targeted tissue regeneration & healing; offering a natural, biologically-active alternative to synthetic medications or pharmaceuticals.
Our team of Australian educators, technical specialists, sales & clinic support staff are all science or health-qualified professionals to support clinicians with timely, evidence-based support, tailored to Australian regulatory standards.
Alocuro ‘platelet-concentrating’ device sets are ARTG-listed as Class IIA medical devices, with the associated equipment technologies, supplied by Alocuro Skin Devices, also ARTG-listed as Class IIA medical devices.
Alocuro ‘platelet-concentrating’ system is unique in its ability to customise the patient’s own PRP or PRF to match the clinical need.
When using Alocuro PRP, the Clinician can customise the PRP or PRF procedure for every patient; considering the patient’s baseline platelet count, the clinical indication, their individual medical history and the treatment scope.
The PRP ‘formulation’ required for each patient’s situation is unique. For example, a chronic elbow tendon pathology does not require the same ‘platelet dose’ as an osteoarthritic knee joint, or a scalp experiencing hair loss.
With 5 device volumes, the appropriate ‘Platelet Dose’ can be selected to to match the clinical need
Then either a ‘Leukocyte-Reduced’ or ‘Leukocyte-Rich’ protocol can be used.
Once platelets have been collected, the total PRP volume can be adjusted to suit the treatment scope, by including the appropriate volume of plasma.
Why choose Alocuro medical devices?
Alocuro offers expert knowledge within autologous PRP & PRF procedure protocols, to assist clinicians optimise their patient outcomes.
A simple to use, ARTG-listed system, that delivers consistent platelet collection efficiency of 90%, after a single-spin centrifugation of 5 minutes.
The Alocuro system offers 5 volumes in platelet-concentrating devices.
Both leukocyte-reduced and leukocyte-rich PRP formulations can be achieved using Alocuro’s system, with customisable platelet concentration and total PRP , PRF volume
As platelets become visible during every Alocuro PRP collection, clinicians can confidently verify the system delivers 90% platelet collection efficiency within a closed, gel-free, sterile platform.
This level of reproducibility allows practitioners to reliably match platelet dose to clinical indication, supporting reproducibility and improved outcomes in tissue repair and recovery.
Fully customisable for platelet dose, PRP type, plasma volume, resting or activated platelets.
Australian-first, clinical trials for use of intra-uterine PRP prior to embryo transfer, and intra-ovarian PRP for poor ovarian reserve.
Advancing healing, tissue repair and recovery through next-generation ‘platelet-concentrating’ systems
Alocuro’s technology is designed to deliver reproducible, evidence-based, and clinically validated outcomes by ensuring platelet dose consistently meets therapeutic thresholds.
Through its commitment to research, clinical training, and scientific support, Alocuro is advancing the role of ‘autologous regenerative medicine’ ARM procedures in Australia & New Zealand, empowering clinicians to deliver effective, patient-customised treatments across:
Orthopaedics
Sports Medicine
Fertility
Dermatology
Plastic Surgery
Rheumatology
Pain Medicine
Wound Care
Dental
Surgical
Ophthalmology
Genito-Urinary
See Alocuro Devices in Action
Explore real-world demonstrations of Alocuro’s PRO-PRP system and clinical applications in motion. These videos showcase practical techniques, device handling, and treatment insights from our partnering practitioners, from @alocuro_prp Instagram feed.
Understanding Regenerative Medicine
Regenerative Medicine refers to a range of innovative medical therapies designed to repair, restore, and regenerate damaged cells, tissues, or organs within the body. These treatments aim to stimulate the body’s natural healing processes to recover function loss due to injury, disease, or ageing.
Autologous therapies use the patient’s own biological material; meaning the donor and recipient are the same person. For example, in autologous platelet-rich plasma (PRP) therapy, PRP is prepared from the patient’s own blood, and reintroduced into the body at the target site to promote healing.
Point-of-care therapy describes a treatment that can be performed entirely within the medical practitioner’s clinic, eliminating the need for hospital or day-surgery admission. The process from sample collection to re-injection, occurs conveniently at the patient’s bedside.
While non-surgical treatment options for musculoskeletal and degenerative conditions are limited, regenerative medicine offers a promising alternative. In cases where the body can no longer repair itself, particularly in tissues with poor blood supply, regenerative treatments can reactivate the healing process.
In tissues that have ‘disrupted’ physiology, the platelet-released bioactive proteins may initiate and sustain a ‘biological reset’ and allow stimulus for the tissue to function in a more normalised and healthy manner.
Alocuro is a medical and dental practitioner only range of PRP medical devices in accordance with TGA regulation of PRP. Practitioners who use Alocuro PRO-PRP devices have completed PRP manufacture and injection training in their specific PRP procedure areas. Registered Nurses or Nurse Practitioners can perform PRP procedures covered within their insured scope of practice, when the patient is under the care of a supervising medical or dental practitioner.
Get in touch to explore how PRP can elevate your practice
FAQ’s
-
Within Australia, in accordance with TGA regulation of PRP (blood and blood products), Alocuro will only sell a PRP system, PRP kits and procedural training to medical, dental practitioners and clinical research facilities. Registered nurses or nurse practitioners who are working with an Alocuro trained medical practitioner who will provide professional supervision of the PRP procedure and who will be responsible for patient care are also supplied. We are unable to supply all other health practitioners or non-health practitioners - in line with the general TGA regulation of PRP procedures within Australia.
-
PRP is an abbreviation for Platelet Rich Plasma. Plasma is the liquid portion of blood which houses all the cellular components such as red and white blood cells, as well as platelets. PRP is simply plasma rich in platelets.
-
PRP is a non-surgical treatment to aid healing - used in many fields, including sports medicine and orthopaedics. In the field of non-surgical orthopaedics, PRP is injected into the affected region to stimulate and enhance cellular regeneration. PRP is a small portion of the patient's own blood that contains large doses of the body’s healing proteins that are stored in platelets. The medical term for these proteins is ‘Growth Factors’.
-
Based on current research, the following areas have been proven to be most responsive to PRP:
orthopaedic and sports related processes: tendonitis, tendinosis, partial tendon tears, ligament sprains or partial tears, and partial muscle tears that have not improved after conservative treatment - physiotherapy protocols, rest etc. PRP has also been effective at treating inflamed synovium and some areas of cartilage found in early to moderate osteoarthritis. PRP has been proven by many high quality clinical trials to reduce pain and improve joint function for osteoarthritic joints - especially knees.
dermatology: healing of skin wounds - acute traumatic and chronic, hard to heal wounds; cosmetic skin rejuvenation and scar minimisation
hair: hair restoration in male and female pattern baldness, hair regrowth in auto-immune hair loss disorders
surgical : multiple surgical applications to assist wound, bone, muscle, tendon , ligament healing
dental: used with implants and for treating advanced periodontal disease.
-
Platelet Rich Plasma was first used in cardiac surgery in 1987 after an open heart operation to avoid blood transfusion. The next area in medicine to adopt the therapy was dental surgery where it has been safely used for over 20 years. More recently it has been utilised in plastic surgery, cardiothoracic surgery, implant surgery, and spinal fusion surgery. Latest advancements in technology have allowed the positive outcomes from these intra-operative applications to be replicated in the outpatient clinic setting. Incorporation of latest PRP research into clinical practice in the fields of orthopaedic, musculoskeletal, dermatology and wound healing applications has provided excellent non-surgical patient management with positive outcomes.
Alocuro is continually reviewing cutting-edge research, and observational data through clinical use to ensure that Alocuro’s PRP therapy protocols offer the patient the best possible outcome from PRO-PRP.
-
There is no current medical technique, product or device that can 100% guarantee it can ‘cure’ injured or degenerative tissue, nor is there any guarantee of Alocuro’s PRP therapy providing the desired healing outcome in every patient case. However, there have been over 10,000 published research articles on the use of PRP to improve healing in humans, and also veterinary applications. The best protocols and applications of PRP from the more recent research have been incorporated into Alocuro’s Pro-PRP system. When these protocols are followed, the patient’s own healing ability should be improved at the local injection or wound application site and it is hoped this will lead to a shorter recovery time with reduced pain and disability for their injury or chronic problem.
Alocuro’s PRO-PRP device and our specific protocol has been developed in conjunction with leading clinicians, biomedical engineers and scientists, to ensure that the PRP therapy can provide optimal healing benefit.
-
PRP therapy has gained significant media attention due to a number of high profile athletes crediting their fast recovery time and improved performance due to a reduction in pain from PRP therapy. Recent sporting personalities who have credited PRP therapy as the likely reason for their rapid return to tournament success include: golfer Tiger Woods, tennis players Rafael Nadal and Maria Sharapova and the late NBA star, Kobe Bryant.
The International Olympic Committee (IOC) and the World Anti-Doping Agency (WADA) allow the use of PRP therapy in all applications for elite athletes ( 2014).
-
In order to benefit from these natural healing growth factors the platelets must first be concentrated. This is a brief summary of the Alocuro PRO-PRP protocol.
To prepare PRP, up to 60mls of blood is taken from the patient using a venepuncture technique, almost identical to having a standard blood collection for pathology testing. The blood sample is then carefully introduced into the Alocuro PRO-PRP device, which is then placed in a centrifuge. A specific protocol of centrifugation is used to isolate a platelet rich plasma (PRP) component of the blood from the whole blood sample. This PRP component is then extracted from the device and under strict aseptic conditions is carefully injected to the site of injured or degenerative tissue. The entire process takes less than 30 minutes, and can be completed as an outpatient procedure.
